Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

Iron is an essential trace mineral element in almost all living cells and organisms. However, cellular iron metabolism pathways are disturbed in most cancer cell types. Cancer cells have a high demand of iron. To maintain rapid growth and proliferation, cancer cells absorb large amounts of iron by altering expression of iron metabolism related proteins. However, iron can catalyze the production of reactive oxygen species (ROS) through Fenton reaction. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is an important player in the resistance to oxidative damage by inducing the transcription of antioxidant genes. Aberrant activation of Nrf2 is observed in most cancer cell types. It has been revealed that the over-activation of Nrf2 promotes cell proliferation, suppresses cell apoptosis, enhances the self-renewal capability of cancer stem cells, and even increases the chemoresistance and radioresistance of cancer cells. Recently, several genes involving cellular iron homeostasis are identified under the control of Nrf2. Since cancer cells require amounts of iron and Nrf2 plays pivotal roles in oxidative defense and iron metabolism, it is highly probable that Nrf2 is a potential modulator orchestrating iron homeostasis and redox balance in cancer cells. In this hypothesis, we summarize the recent findings of the role of iron and Nrf2 in cancer cells and demonstrate how Nrf2 balances the oxidative stress induced by iron through regulating antioxidant enzymes and iron metabolism. This hypothesis provides new insights into the role of Nrf2 in cancer progression. Since ferroptosis is dependent on lipid peroxide and iron accumulation, Nrf2 inhibition may dramatically increase sensitivity to ferroptosis. The combination of Nrf2 inhibitors with ferroptosis inducers may exert greater efficacy on cancer therapy.

Abstract licence: CC BY

1. 7.

   Role of Nrf2 in bone metabolism · 2015

2. 18.

   Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2 · 2015

3. 57.

   Heme oxygenase-1: emerging target of cancer therapy · 2015

4. 62.

   Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling · 2011

5. 65.

   Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death · 2015

6. 106.

   Unsolved mysteries: How does lipid peroxidation cause ferroptosis? · 2018

7. 121.

   Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro · 2019

8. 122.

   Nrf2 in cancers: A double‐edged sword · 2019

9. 123.
   Corrected

   Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy · 2019

10. 124.

    Potential Applications of NRF2 Inhibitors in Cancer Therapy · 2019

11. 133.

    YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression · 2019

12. 134.

    The Role of Nrf2 Activity in Cancer Development and Progression · 2019

13. 144.

    Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases · 2020

14. 148.

    Ferroptosis in Cancer Treatment: Another Way to Rome · 2020

15. 149.

    Iron Metabolism in Ferroptosis · 2020

16. 152.

    Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis · 2020

17. 157.

    Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents · 2021

18. 158.

    Ferroptosis, radiotherapy, and combination therapeutic strategies · 2021

19. 161.

    Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells · 2021

146 more references, whose wording the paper’s licence keeps private.

• Oxidative Stress: Signaling Pathways, Biological Functions, and Disease · 2025

• Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma · 2023

• The Mechanisms of Ferroptosis Under Hypoxia · 2023

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.